Fennec Pharmaceuticals Inc (FENC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Operating Expenses | 1,250 | 616 | 901 | 944 | 572 |
| Operating Income | -1,250 | -616 | -901 | -944 | -572 |
| Other Income | 648 | 3,331 | 4,409 | -2,200 | 224 |
| Pre-tax Income | -602 | 2,715 | 3,508 | -3,144 | -348 |
| Net Income Continuous | -602 | 2,715 | 3,508 | -3,144 | -348 |
| Net Income | $-602 | $2,715 | $3,508 | $-3,144 | $-348 |
| EPS Basic Total Ops | -0.06 | 0.33 | 0.45 | -0.51 | -0.03 |
| EPS Basic Continuous Ops | -0.07 | 0.32 | 0.47 | -0.52 | -0.04 |
| EPS Diluted Total Ops | -0.06 | 0.33 | 0.54 | -0.51 | -0.03 |
| EPS Diluted Continuous Ops | -0.07 | 0.32 | 0.59 | -0.52 | -0.04 |
| EBITDA(a) | $-1,250 | $-616 | $-901 | $-944 | $-572 |